Clinical Pharmacokinetics of Amantadine Hydrochloride
- First Online:
- 75 Downloads
Amantadine is a drug with diverse uses ranging from prevention of influenza A illness to the treatment of patients with Parkinson’s disease. It is available only in oral formulations from which it is well absorbed and widely distributed, little drug being present in the circulation. Apparent volume of distribution is inversely related to dose over the therapeutic range and accounts in part for a noteworthy logarithmic increase in plasma concentration as a function of dose. Elimination is primarily by renal clearance by both glomerular filtration and tubular secretion.
Amantadine accumulates in patients with renal dysfunction. Hence, doses must be reduced in such patients to avoid toxicity. Interactions with other drugs appear uncommon.
Relationships have been demonstrated between amantadine therapeutic effects and plasma concentrations in different study cohorts, but not in individual patients. Dose schedules have been suggested for individuals in whom amantadine kinetics are different from healthy subjects. However, these schedules are controversial in their choice of target concentrations and in being untested as to predictive value.
Unable to display preview. Download preview PDF.
- Aoki FY, Sitar DS. Effects of chronic amantadine hydrochloride ingestion on its and paracetamol pharmacokinetics in young adults. Submitted for publication, 1987bGoogle Scholar
- Aoki FY, Sitar DS, Ogilvie RI. Amantadine kinetics in healthy young subjects after long-term dosing. Clinical Pharmacology and Therapeutics 26: 727–736, 1979Google Scholar
- Centers for Disease Control, Department of Health and Human Sciences. Recommendations for prevention and control of influenza. Annals of Internal Medicine 105: 399–404, 1986Google Scholar
- Crispens CG. Handbook on the laboratory mouse, pp. 82–90, Charles C. Thomas, Springfield, 1975Google Scholar
- Fasano VA, Urciuoli R, Broggi G. Prime osservazioni sull’uso dell’Amantadina per via endovenosa e delle associazione dell’Amantadina per via orale con farmaci anticolinergici e con levo-dopa nel trattamento della malattia di Parkinson. Minerva Medica (Torino) 61: 2895–2903, 1970Google Scholar
- Finklea JF, Hennessy AV, Davenport FM. A field trial of amantadine prophylaxis in naturally occurring acute respiratory illness. American Journal of Epidemiology 65: 403–412, 1967Google Scholar
- Geuens HF, Stephens RL. Influence of the pH of the urine on the rate of excretion of 1-adamantanamine. 5th International Congress of Chemotherapy, Vienna, June 26–July 1, 1967, pp. 703–713, Verlag der Wiener Medizinischen Akademie, Vienna, 1967Google Scholar
- Gill MJ, Sitar DS, Aoki FY. Initial pharmacokinetic evaluation of amantadine hydrochloride administered intravenously to young healthy volunteers. Abstract. Clinical and Investigative Medicine 5: 5B, 1982Google Scholar
- Jackson GG, Stanley ED, Muldoon RL. Chemoprophylaxis of viral respiratory diseases. 1st International Conference on Vaccines against Viral and Rickettsial Diseases of Man, p. 595, Scientific publication no. 147, Pan American World Health Organization, Washington, DC, 1967Google Scholar
- Leeming JK. Amantadine hydrochloride and the elderly. Lancet 1: 313–314, 1969Google Scholar
- Parkes D. Amantadine. Advances in Drug Research 8: 8–11, 1974Google Scholar
- Peacocke J, Eadie J. Influenza. Canada Diseases Weekly Report 6: 242–243, 1980Google Scholar
- Smith CB, Purcell RH, Chancock RM. Effect of amantadine hydrochloride on parainfluenza type 1 virus infections in adult volunteers. American Review of Respiratory Diseases 95: 689–690, 1967Google Scholar
- Solovyov VN, Tolmacheva NS. Therapeutic effect of amantadine aerosol in experimental influenza infection of white mice. Acta Virology 11: 482–487, 1967Google Scholar
- Taylor Dickinson PC, Chang TW, Weinstein L. Effects of amantadine on influenza B and measles virus infection in children. In Proceedings of the 6th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Philadelphia, Oct 26–28, 1966. pp. 521–526, 1967Google Scholar